

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.51439433 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.73599533 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.69973597 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.69973597 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.12615796 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.12615796 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.09667510 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.90598401 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.85822734 |
| 10 | detection of other organism (GO:0098543) | 4.76794992 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.68040286 |
| 12 | detection of bacterium (GO:0016045) | 4.63404578 |
| 13 | B cell receptor signaling pathway (GO:0050853) | 4.58034124 |
| 14 | positive thymic T cell selection (GO:0045059) | 4.55368745 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.51449210 |
| 16 | positive regulation of B cell differentiation (GO:0045579) | 4.48706366 |
| 17 | negative T cell selection (GO:0043383) | 4.47870655 |
| 18 | negative thymic T cell selection (GO:0045060) | 4.43726505 |
| 19 | regulation of B cell differentiation (GO:0045577) | 4.32642399 |
| 20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.17637497 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.00695703 |
| 22 | leukocyte aggregation (GO:0070486) | 3.98033219 |
| 23 | detection of external biotic stimulus (GO:0098581) | 3.94603418 |
| 24 | T cell migration (GO:0072678) | 3.93107474 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.90199144 |
| 26 | negative regulation of T cell mediated immunity (GO:0002710) | 3.89653479 |
| 27 | response to interleukin-15 (GO:0070672) | 3.84097590 |
| 28 | positive T cell selection (GO:0043368) | 3.83708824 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 3.80455038 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 3.80455038 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.80455038 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.80455038 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.80455038 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 3.80455038 |
| 35 | NIK/NF-kappaB signaling (GO:0038061) | 3.78955109 |
| 36 | interferon-gamma production (GO:0032609) | 3.77833031 |
| 37 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.76390704 |
| 38 | thymic T cell selection (GO:0045061) | 3.76286187 |
| 39 | T cell selection (GO:0045058) | 3.72159822 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.63487905 |
| 41 | response to host immune response (GO:0052572) | 3.59012550 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.59012550 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.58977839 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.56602485 |
| 45 | tolerance induction (GO:0002507) | 3.56409484 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.54099912 |
| 47 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.52263661 |
| 48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.52211713 |
| 49 | cellular response to interleukin-15 (GO:0071350) | 3.52014241 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.51670490 |
| 51 | detection of biotic stimulus (GO:0009595) | 3.47018603 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.45241276 |
| 53 | microglial cell activation (GO:0001774) | 3.45195171 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 3.42602893 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.38838156 |
| 56 | regulation of tolerance induction (GO:0002643) | 3.37159007 |
| 57 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.36643604 |
| 58 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.35469250 |
| 59 | response to host (GO:0075136) | 3.32447825 |
| 60 | response to host defenses (GO:0052200) | 3.32447825 |
| 61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32447825 |
| 62 | neutrophil activation (GO:0042119) | 3.32025175 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 3.30996621 |
| 64 | positive regulation of mast cell activation (GO:0033005) | 3.30167647 |
| 65 | regulation of interferon-alpha production (GO:0032647) | 3.30048197 |
| 66 | mature B cell differentiation (GO:0002335) | 3.29094211 |
| 67 | respiratory burst (GO:0045730) | 3.24741905 |
| 68 | myeloid dendritic cell activation (GO:0001773) | 3.23975423 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 3.22742394 |
| 70 | negative regulation of phagocytosis (GO:0050765) | 3.21565391 |
| 71 | cellular extravasation (GO:0045123) | 3.21108947 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.20953706 |
| 73 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.19596601 |
| 74 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18972698 |
| 75 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.17649749 |
| 76 | macrophage activation (GO:0042116) | 3.16853476 |
| 77 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.15688540 |
| 78 | mast cell activation (GO:0045576) | 3.14279151 |
| 79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14072337 |
| 80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.13464036 |
| 81 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.13013474 |
| 82 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.12798574 |
| 83 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.12798574 |
| 84 | B cell homeostasis (GO:0001782) | 3.12152118 |
| 85 | neutrophil mediated immunity (GO:0002446) | 3.11227535 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 3.11027127 |
| 87 | positive regulation of granulocyte differentiation (GO:0030854) | 3.09005119 |
| 88 | positive regulation of interleukin-2 production (GO:0032743) | 3.08697102 |
| 89 | granulocyte activation (GO:0036230) | 3.08505926 |
| 90 | T cell homeostasis (GO:0043029) | 3.08096501 |
| 91 | response to type I interferon (GO:0034340) | 3.06719338 |
| 92 | macrophage activation involved in immune response (GO:0002281) | 3.06403146 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.05470490 |
| 94 | lymphocyte homeostasis (GO:0002260) | 3.05367817 |
| 95 | regulation of mast cell activation (GO:0033003) | 3.05347306 |
| 96 | negative regulation of B cell proliferation (GO:0030889) | 3.04321641 |
| 97 | cellular response to zinc ion (GO:0071294) | 3.02850967 |
| 98 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.02715956 |
| 99 | T cell costimulation (GO:0031295) | 3.01769935 |
| 100 | defense response to protozoan (GO:0042832) | 3.01174910 |
| 101 | leukocyte degranulation (GO:0043299) | 3.00795922 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00291888 |
| 103 | germinal center formation (GO:0002467) | 3.00253689 |
| 104 | negative regulation of innate immune response (GO:0045824) | 3.00022592 |
| 105 | cellular response to type I interferon (GO:0071357) | 2.99637744 |
| 106 | type I interferon signaling pathway (GO:0060337) | 2.99637744 |
| 107 | response to muramyl dipeptide (GO:0032495) | 2.99592831 |
| 108 | myeloid cell activation involved in immune response (GO:0002275) | 2.99484641 |
| 109 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.99322820 |
| 110 | T cell receptor signaling pathway (GO:0050852) | 2.99088269 |
| 111 | negative regulation of interleukin-12 production (GO:0032695) | 2.98296725 |
| 112 | activated T cell proliferation (GO:0050798) | 2.97938165 |
| 113 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.96658010 |
| 114 | lymphocyte costimulation (GO:0031294) | 2.95524276 |
| 115 | leukocyte cell-cell adhesion (GO:0007159) | 2.95250931 |
| 116 | B cell proliferation (GO:0042100) | 2.94840985 |
| 117 | myeloid dendritic cell differentiation (GO:0043011) | 2.94717496 |
| 118 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.94093327 |
| 119 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93884908 |
| 120 | response to protozoan (GO:0001562) | 2.91913932 |
| 121 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90570550 |
| 122 | regulation of B cell proliferation (GO:0030888) | 2.88452510 |
| 123 | positive regulation of isotype switching (GO:0045830) | 2.87893682 |
| 124 | T cell proliferation (GO:0042098) | 2.87405140 |
| 125 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85762869 |
| 126 | positive regulation of tolerance induction (GO:0002645) | 2.84992033 |
| 127 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.84629080 |
| 128 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.83748719 |
| 129 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.82858979 |
| 130 | regulation of antigen processing and presentation (GO:0002577) | 2.82460491 |
| 131 | positive regulation of B cell activation (GO:0050871) | 2.81634371 |
| 132 | response to peptidoglycan (GO:0032494) | 2.80066518 |
| 133 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.78924728 |
| 134 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.78274373 |
| 135 | B cell mediated immunity (GO:0019724) | 2.77587394 |
| 136 | natural killer cell mediated immunity (GO:0002228) | 2.76487532 |
| 137 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.76487532 |
| 138 | natural killer cell differentiation (GO:0001779) | 2.74012678 |
| 139 | regulation of response to interferon-gamma (GO:0060330) | 2.72957734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.35055745 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.17290958 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.58258711 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.29387710 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.27699783 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.82682335 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.55053810 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40534847 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.25757589 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.20847730 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.19016276 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07412793 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.98587895 |
| 14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.96773255 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.95528891 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.82308964 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79124006 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.69103645 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.68829436 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.67584830 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.65664595 |
| 22 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.62910906 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.49169495 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.44792234 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42673309 |
| 26 | * MYB_26560356_Chip-Seq_TH1_Human | 2.38714361 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.35489162 |
| 28 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26553422 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.18344661 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16378422 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.14467642 |
| 32 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.13558207 |
| 33 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08037833 |
| 34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03985161 |
| 35 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.00491976 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97254612 |
| 37 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95534834 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83758453 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82072598 |
| 40 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68458603 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66677734 |
| 42 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.63314039 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62528653 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62368850 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58830472 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57232302 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.57103429 |
| 48 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.55516230 |
| 49 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50800280 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47115731 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46069583 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44628656 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43732302 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42627302 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42556151 |
| 56 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.41408309 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39954713 |
| 58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39874123 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35230832 |
| 60 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.34624854 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28920972 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28846656 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27479551 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27082565 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26711589 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25433692 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22738322 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22241383 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19124266 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18933499 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16651452 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15929482 |
| 73 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.15453211 |
| 74 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15292012 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13919578 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13122118 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11116699 |
| 78 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08714709 |
| 79 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08049711 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04129535 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04045966 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02488572 |
| 83 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00384789 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98809686 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98423956 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97047089 |
| 87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95091496 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95088111 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94594038 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93986731 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93020574 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92953572 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92014312 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91792252 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91741495 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91299070 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88858004 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86801742 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86111412 |
| 100 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85070498 |
| 101 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84995922 |
| 102 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.84944103 |
| 103 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.83246393 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82464536 |
| 105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82286361 |
| 106 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.80599165 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80383375 |
| 108 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.80253134 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80242051 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80210046 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.79545260 |
| 112 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.79085173 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.76087782 |
| 114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.73234951 |
| 115 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71781534 |
| 116 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67578589 |
| 117 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67430363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.50371530 |
| 2 | MP0001800_abnormal_humoral_immune | 3.42200903 |
| 3 | MP0000685_abnormal_immune_system | 3.35737637 |
| 4 | MP0001790_abnormal_immune_system | 3.34384583 |
| 5 | MP0005387_immune_system_phenotype | 3.34384583 |
| 6 | MP0005671_abnormal_response_to | 3.32149195 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.98341694 |
| 8 | MP0002452_abnormal_antigen_presenting | 2.97340508 |
| 9 | MP0003303_peritoneal_inflammation | 2.89581435 |
| 10 | MP0003436_decreased_susceptibility_to | 2.87370535 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.86876516 |
| 12 | MP0002723_abnormal_immune_serum | 2.78857941 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.73811084 |
| 14 | MP0001819_abnormal_immune_cell | 2.71336599 |
| 15 | MP0009785_altered_susceptibility_to | 2.62836373 |
| 16 | MP0005025_abnormal_response_to | 2.56328557 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.54889870 |
| 18 | MP0002419_abnormal_innate_immunity | 2.54839685 |
| 19 | MP0002398_abnormal_bone_marrow | 2.52227263 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.50525273 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.33958025 |
| 22 | MP0000716_abnormal_immune_system | 2.30702748 |
| 23 | MP0002405_respiratory_system_inflammati | 2.17232179 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.14887114 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.12408843 |
| 26 | MP0001873_stomach_inflammation | 2.08822947 |
| 27 | MP0000569_abnormal_digit_pigmentation | 2.07948158 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.06695610 |
| 29 | MP0002006_tumorigenesis | 2.03223185 |
| 30 | MP0006082_CNS_inflammation | 2.02943819 |
| 31 | MP0002722_abnormal_immune_system | 2.02937338 |
| 32 | MP0004510_myositis | 1.94523784 |
| 33 | MP0002429_abnormal_blood_cell | 1.91349484 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.90721740 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.85938159 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.85060489 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.83436739 |
| 38 | MP0004947_skin_inflammation | 1.82647348 |
| 39 | MP0005174_abnormal_tail_pigmentation | 1.81888399 |
| 40 | MP0001853_heart_inflammation | 1.78039588 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.74566569 |
| 42 | MP0009278_abnormal_bone_marrow | 1.70555823 |
| 43 | MP0008260_abnormal_autophagy | 1.67698265 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.62344150 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.55299310 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.51857240 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.51857240 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.51402253 |
| 49 | MP0003724_increased_susceptibility_to | 1.49494427 |
| 50 | MP0005451_abnormal_body_composition | 1.48469967 |
| 51 | MP0005310_abnormal_salivary_gland | 1.45843950 |
| 52 | MP0003866_abnormal_defecation | 1.39299751 |
| 53 | MP0002933_joint_inflammation | 1.37781498 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.37389214 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.30213483 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.29549386 |
| 57 | MP0003448_altered_tumor_morphology | 1.27364207 |
| 58 | MP0008469_abnormal_protein_level | 1.25036357 |
| 59 | MP0010307_abnormal_tumor_latency | 1.24103626 |
| 60 | MP0000858_altered_metastatic_potential | 1.21909211 |
| 61 | MP0004883_abnormal_blood_vessel | 1.20636212 |
| 62 | MP0000490_abnormal_crypts_of | 1.18244577 |
| 63 | MP0008057_abnormal_DNA_replication | 1.10895345 |
| 64 | MP0003690_abnormal_glial_cell | 1.07502862 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.06929404 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.05532164 |
| 67 | MP0005076_abnormal_cell_differentiation | 1.04801305 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 1.01069374 |
| 69 | MP0002019_abnormal_tumor_incidence | 0.96905197 |
| 70 | MP0000371_diluted_coat_color | 0.92625559 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.91483397 |
| 72 | MP0001851_eye_inflammation | 0.91125922 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.90951486 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.87554250 |
| 75 | MP0005164_abnormal_response_to | 0.84733376 |
| 76 | MP0010094_abnormal_chromosome_stability | 0.82549098 |
| 77 | MP0009764_decreased_sensitivity_to | 0.82297256 |
| 78 | MP0003077_abnormal_cell_cycle | 0.81592721 |
| 79 | MP0002009_preneoplasia | 0.80461349 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.75438351 |
| 81 | MP0005390_skeleton_phenotype | 0.73653339 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.72010217 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.71869591 |
| 84 | MP0003693_abnormal_embryo_hatching | 0.70485408 |
| 85 | MP0009840_abnormal_foam_cell | 0.69525426 |
| 86 | MP0003828_pulmonary_edema | 0.69522095 |
| 87 | MP0009763_increased_sensitivity_to | 0.67503335 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.67492748 |
| 89 | MP0000343_altered_response_to | 0.65872848 |
| 90 | MP0003091_abnormal_cell_migration | 0.63672989 |
| 91 | MP0002132_abnormal_respiratory_system | 0.63669028 |
| 92 | MP0003045_fibrosis | 0.62665499 |
| 93 | MP0004381_abnormal_hair_follicle | 0.61275463 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.61129240 |
| 95 | MP0005166_decreased_susceptibility_to | 0.60892735 |
| 96 | MP0001663_abnormal_digestive_system | 0.60252866 |
| 97 | MP0003111_abnormal_nucleus_morphology | 0.59876787 |
| 98 | MP0008004_abnormal_stomach_pH | 0.59080617 |
| 99 | MP0000604_amyloidosis | 0.58915958 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.58527830 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.58380071 |
| 102 | MP0000313_abnormal_cell_death | 0.57808503 |
| 103 | MP0008874_decreased_physiological_sensi | 0.57150329 |
| 104 | MP0000249_abnormal_blood_vessel | 0.56736240 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56249764 |
| 106 | MP0005023_abnormal_wound_healing | 0.56195983 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.53355789 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.51992016 |
| 109 | MP0003795_abnormal_bone_structure | 0.51685654 |
| 110 | MP0004130_abnormal_muscle_cell | 0.50754529 |
| 111 | MP0002928_abnormal_bile_duct | 0.50353689 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.50208310 |
| 113 | MP0003806_abnormal_nucleotide_metabolis | 0.48840609 |
| 114 | MP0005621_abnormal_cell_physiology | 0.48375417 |
| 115 | MP0003075_altered_response_to | 0.47858518 |
| 116 | MP0000609_abnormal_liver_physiology | 0.45094661 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.44871231 |
| 118 | MP0009115_abnormal_fat_cell | 0.43814015 |
| 119 | MP0005388_respiratory_system_phenotype | 0.42137038 |
| 120 | MP0002133_abnormal_respiratory_system | 0.42137038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.33069610 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.92553071 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.89376708 |
| 4 | Recurrent viral infections (HP:0004429) | 4.85942994 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.65732150 |
| 6 | Agammaglobulinemia (HP:0004432) | 4.16336825 |
| 7 | Myositis (HP:0100614) | 4.09275418 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 4.08240853 |
| 9 | Chronic otitis media (HP:0000389) | 4.07073886 |
| 10 | IgM deficiency (HP:0002850) | 4.06519906 |
| 11 | Recurrent bronchitis (HP:0002837) | 4.05006259 |
| 12 | T lymphocytopenia (HP:0005403) | 4.03514551 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.94481131 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.90722340 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.90514379 |
| 16 | Meningitis (HP:0001287) | 3.83279669 |
| 17 | Cellulitis (HP:0100658) | 3.80457547 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.77022510 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.77022510 |
| 20 | Inflammation of the large intestine (HP:0002037) | 3.76058484 |
| 21 | Colitis (HP:0002583) | 3.68274707 |
| 22 | Recurrent skin infections (HP:0001581) | 3.66220500 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.61996345 |
| 24 | Gastrointestinal inflammation (HP:0004386) | 3.61996039 |
| 25 | Vasculitis (HP:0002633) | 3.42865199 |
| 26 | Abnormality of T cells (HP:0002843) | 3.42791928 |
| 27 | Abnormality of the fingertips (HP:0001211) | 3.32097177 |
| 28 | Thyroiditis (HP:0100646) | 3.30873704 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.30275881 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.28717692 |
| 31 | Optic neuritis (HP:0100653) | 3.28717692 |
| 32 | Urticaria (HP:0001025) | 3.25848726 |
| 33 | B lymphocytopenia (HP:0010976) | 3.24362458 |
| 34 | Abnormality of B cell number (HP:0010975) | 3.24362458 |
| 35 | Nasal polyposis (HP:0100582) | 3.23877352 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21904962 |
| 37 | Obstructive lung disease (HP:0006536) | 3.21904962 |
| 38 | Spontaneous hematomas (HP:0007420) | 3.16036866 |
| 39 | Orchitis (HP:0100796) | 3.15994664 |
| 40 | Pustule (HP:0200039) | 3.14957297 |
| 41 | Abnormality of macrophages (HP:0004311) | 3.12543024 |
| 42 | Gastrointestinal stroma tumor (HP:0100723) | 3.10793061 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 3.07156112 |
| 44 | Lymphopenia (HP:0001888) | 3.04489867 |
| 45 | Eosinophilia (HP:0001880) | 3.00066334 |
| 46 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.94732535 |
| 47 | Thrombocytosis (HP:0001894) | 2.94236263 |
| 48 | Verrucae (HP:0200043) | 2.89934717 |
| 49 | Papilloma (HP:0012740) | 2.89934717 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.86146933 |
| 51 | Hypochromic anemia (HP:0001931) | 2.83885011 |
| 52 | Recurrent sinusitis (HP:0011108) | 2.83294432 |
| 53 | Severe combined immunodeficiency (HP:0004430) | 2.78183511 |
| 54 | Stomatitis (HP:0010280) | 2.77406551 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.76946191 |
| 56 | Leukocytosis (HP:0001974) | 2.75820286 |
| 57 | Osteomyelitis (HP:0002754) | 2.75047316 |
| 58 | Periodontitis (HP:0000704) | 2.72879715 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.71780106 |
| 60 | Increased IgM level (HP:0003496) | 2.71539771 |
| 61 | Pulmonary infiltrates (HP:0002113) | 2.70211418 |
| 62 | IgG deficiency (HP:0004315) | 2.69147011 |
| 63 | Gingivitis (HP:0000230) | 2.68950274 |
| 64 | Granulocytopenia (HP:0001913) | 2.68726005 |
| 65 | Chronic diarrhea (HP:0002028) | 2.68013375 |
| 66 | Encephalitis (HP:0002383) | 2.67014861 |
| 67 | Increased IgE level (HP:0003212) | 2.66090277 |
| 68 | Combined immunodeficiency (HP:0005387) | 2.66027585 |
| 69 | Arterial thrombosis (HP:0004420) | 2.64413753 |
| 70 | IgA deficiency (HP:0002720) | 2.58683337 |
| 71 | Abnormality of eosinophils (HP:0001879) | 2.57780800 |
| 72 | Pulmonary embolism (HP:0002204) | 2.53274414 |
| 73 | Chronic sinusitis (HP:0011109) | 2.51327868 |
| 74 | Recurrent pneumonia (HP:0006532) | 2.48836491 |
| 75 | Emphysema (HP:0002097) | 2.47005403 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.42989466 |
| 77 | Hematochezia (HP:0002573) | 2.42464359 |
| 78 | Episodic fever (HP:0001954) | 2.41981882 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 2.38940827 |
| 80 | Anorexia (HP:0002039) | 2.38609307 |
| 81 | Hemoptysis (HP:0002105) | 2.36441891 |
| 82 | Recurrent lower respiratory tract infections (HP:0002783) | 2.32042333 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 2.31676452 |
| 84 | Chest pain (HP:0100749) | 2.31109049 |
| 85 | Lymphoma (HP:0002665) | 2.30516504 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30453912 |
| 87 | Petechiae (HP:0000967) | 2.29534033 |
| 88 | Gingival bleeding (HP:0000225) | 2.29501394 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 2.26693407 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 2.26321410 |
| 91 | Viral hepatitis (HP:0006562) | 2.25675777 |
| 92 | Abnormality of the pleura (HP:0002103) | 2.22558219 |
| 93 | Sepsis (HP:0100806) | 2.19499985 |
| 94 | Bronchitis (HP:0012387) | 2.17869701 |
| 95 | Epistaxis (HP:0000421) | 2.17400135 |
| 96 | Microcytic anemia (HP:0001935) | 2.15470349 |
| 97 | Gangrene (HP:0100758) | 2.13949577 |
| 98 | Restrictive lung disease (HP:0002091) | 2.13685852 |
| 99 | Skin ulcer (HP:0200042) | 2.12094949 |
| 100 | Slow saccadic eye movements (HP:0000514) | 2.12049839 |
| 101 | Amyloidosis (HP:0011034) | 2.10485656 |
| 102 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09668551 |
| 103 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09668551 |
| 104 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09668551 |
| 105 | Keratoconjunctivitis (HP:0001096) | 2.06001370 |
| 106 | Purpura (HP:0000979) | 2.05747244 |
| 107 | Leukopenia (HP:0001882) | 2.04961364 |
| 108 | Papilledema (HP:0001085) | 2.02390371 |
| 109 | Glomerulopathy (HP:0100820) | 2.01771051 |
| 110 | Loss of speech (HP:0002371) | 2.00128621 |
| 111 | Abnormality of the peritoneum (HP:0002585) | 2.00048696 |
| 112 | Systemic lupus erythematosus (HP:0002725) | 1.98778019 |
| 113 | Increased cerebral lipofuscin (HP:0011813) | 1.98543785 |
| 114 | Abnormality of the prostate (HP:0008775) | 1.98169194 |
| 115 | Premature loss of primary teeth (HP:0006323) | 1.98047082 |
| 116 | Gastrointestinal infarctions (HP:0005244) | 1.97263646 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 1.96212204 |
| 118 | Abnormal platelet function (HP:0011869) | 1.95660454 |
| 119 | Impaired platelet aggregation (HP:0003540) | 1.95660454 |
| 120 | Peritonitis (HP:0002586) | 1.94652476 |
| 121 | Skin rash (HP:0000988) | 1.92438951 |
| 122 | Hypoplasia of the thymus (HP:0000778) | 1.91428484 |
| 123 | Myocardial infarction (HP:0001658) | 1.91114390 |
| 124 | Abnormality of the endocardium (HP:0004306) | 1.90896823 |
| 125 | Increased serum ferritin (HP:0003281) | 1.90778397 |
| 126 | Abnormal platelet volume (HP:0011876) | 1.90165667 |
| 127 | Fatigue (HP:0012378) | 1.89072094 |
| 128 | Cheilitis (HP:0100825) | 1.86586475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.27946149 |
| 2 | PRPF4B | 3.03144616 |
| 3 | TYK2 | 2.97433071 |
| 4 | TXK | 2.95775329 |
| 5 | MAP3K14 | 2.73663629 |
| 6 | JAK3 | 2.58149939 |
| 7 | BLK | 2.47663227 |
| 8 | IRAK4 | 2.46784952 |
| 9 | STK10 | 2.32628295 |
| 10 | KIT | 2.22687062 |
| 11 | ZAP70 | 2.20674466 |
| 12 | BTK | 2.12249190 |
| 13 | JAK1 | 2.09214346 |
| 14 | GRK6 | 2.08298270 |
| 15 | CSF1R | 2.05726704 |
| 16 | MAP3K10 | 2.02902955 |
| 17 | ITK | 2.01236739 |
| 18 | IKBKE | 2.00718106 |
| 19 | TBK1 | 2.00369834 |
| 20 | SYK | 1.99927442 |
| 21 | RIPK4 | 1.92074096 |
| 22 | MAP3K13 | 1.91189974 |
| 23 | SIK2 | 1.83592778 |
| 24 | EEF2K | 1.76129472 |
| 25 | TEC | 1.69292081 |
| 26 | IKBKB | 1.66628723 |
| 27 | HCK | 1.65214812 |
| 28 | CSK | 1.60194628 |
| 29 | LCK | 1.56696987 |
| 30 | CDK12 | 1.51146300 |
| 31 | FGFR3 | 1.48584522 |
| 32 | FGFR4 | 1.46220391 |
| 33 | TGFBR2 | 1.45549600 |
| 34 | IRAK3 | 1.44341040 |
| 35 | ERN1 | 1.41858462 |
| 36 | FES | 1.41611656 |
| 37 | TAOK1 | 1.35851948 |
| 38 | MAP3K3 | 1.32447346 |
| 39 | LRRK2 | 1.29721693 |
| 40 | MARK3 | 1.28065804 |
| 41 | TAOK3 | 1.27146013 |
| 42 | PIM1 | 1.26046679 |
| 43 | CLK1 | 1.25811320 |
| 44 | EPHB1 | 1.22003382 |
| 45 | LYN | 1.20827625 |
| 46 | MAP3K11 | 1.20104113 |
| 47 | CHUK | 1.08435625 |
| 48 | MAP3K1 | 1.07052231 |
| 49 | PKN2 | 1.00382685 |
| 50 | KSR2 | 0.96730670 |
| 51 | STK4 | 0.96556798 |
| 52 | RPS6KA4 | 0.96035409 |
| 53 | MARK2 | 0.95965504 |
| 54 | SMG1 | 0.93399640 |
| 55 | NLK | 0.91833229 |
| 56 | JAK2 | 0.90091953 |
| 57 | NEK2 | 0.89448042 |
| 58 | MAP2K3 | 0.89098737 |
| 59 | BMPR2 | 0.88560958 |
| 60 | PRKCQ | 0.82883716 |
| 61 | CDK4 | 0.82288610 |
| 62 | FLT3 | 0.80477784 |
| 63 | SIK3 | 0.78799143 |
| 64 | PRKD2 | 0.76850873 |
| 65 | CAMK1D | 0.76706944 |
| 66 | TRIB3 | 0.73051737 |
| 67 | CDK6 | 0.72775799 |
| 68 | TTN | 0.70407947 |
| 69 | CDC42BPA | 0.69933566 |
| 70 | TNK2 | 0.69507917 |
| 71 | TAOK2 | 0.68837924 |
| 72 | PDPK1 | 0.68296489 |
| 73 | CAMKK1 | 0.67373247 |
| 74 | NEK9 | 0.65442503 |
| 75 | MST4 | 0.64771717 |
| 76 | CAMK1G | 0.63897865 |
| 77 | BRD4 | 0.61468367 |
| 78 | IRAK2 | 0.59922766 |
| 79 | PTK6 | 0.59351588 |
| 80 | CAMKK2 | 0.58651823 |
| 81 | HIPK2 | 0.58439459 |
| 82 | PASK | 0.57750594 |
| 83 | TRPM7 | 0.57472404 |
| 84 | PIK3CG | 0.55623809 |
| 85 | ALK | 0.52527096 |
| 86 | CDK9 | 0.52395589 |
| 87 | EPHA3 | 0.50401636 |
| 88 | PRKCH | 0.49150044 |
| 89 | MAP3K6 | 0.49079247 |
| 90 | FGR | 0.48872424 |
| 91 | CDK19 | 0.47080578 |
| 92 | NME2 | 0.46298964 |
| 93 | PDK1 | 0.45439075 |
| 94 | ABL1 | 0.44463836 |
| 95 | MAP3K8 | 0.43843023 |
| 96 | EGFR | 0.43626731 |
| 97 | YES1 | 0.41983367 |
| 98 | DYRK1B | 0.41831367 |
| 99 | MAP3K7 | 0.41798928 |
| 100 | MAPKAPK2 | 0.41632640 |
| 101 | STK11 | 0.40935391 |
| 102 | SIK1 | 0.40897094 |
| 103 | ATR | 0.40854003 |
| 104 | RPS6KA6 | 0.38616128 |
| 105 | GRK7 | 0.38306166 |
| 106 | MATK | 0.37521473 |
| 107 | RET | 0.37225726 |
| 108 | MELK | 0.37176694 |
| 109 | TESK2 | 0.37074183 |
| 110 | MAPK4 | 0.36479571 |
| 111 | MAP3K5 | 0.36275609 |
| 112 | MAP2K2 | 0.35343157 |
| 113 | MAPK11 | 0.35036867 |
| 114 | RAF1 | 0.33247704 |
| 115 | PIM2 | 0.32851734 |
| 116 | FYN | 0.32287640 |
| 117 | PDGFRB | 0.31961222 |
| 118 | MAP3K2 | 0.31365713 |
| 119 | SCYL2 | 0.30365800 |
| 120 | PTK2B | 0.29890300 |
| 121 | MAPK7 | 0.29770800 |
| 122 | CDC7 | 0.29604785 |
| 123 | SGK3 | 0.29589426 |
| 124 | RPS6KA5 | 0.29020326 |
| 125 | RPS6KC1 | 0.28941857 |
| 126 | RPS6KL1 | 0.28941857 |
| 127 | STK38 | 0.28710980 |
| 128 | PRKCD | 0.27927214 |
| 129 | IRAK1 | 0.27517988 |
| 130 | MAPK12 | 0.25122229 |
| 131 | STK24 | 0.24739768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.00966619 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.06798760 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.78965773 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69088086 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49709286 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.46552010 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.39531502 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.38384874 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.22517510 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.21920876 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.19463542 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.08330504 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90887133 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88186337 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.79854951 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77346811 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72423089 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71325968 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70468481 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69712935 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.61207503 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.60376177 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56254830 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.56192277 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.55766681 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52063529 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.51471624 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.40347473 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.39780213 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37008555 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.35788053 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31205594 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31104374 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30908575 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.29361504 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28021888 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27704265 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25946514 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.25615855 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.23376623 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23206573 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09378420 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08677018 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07115789 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.06323394 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04595163 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.03614975 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.03441675 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.01126925 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00456051 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.96806545 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.92802297 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.91343421 |
| 54 | DNA replication_Homo sapiens_hsa03030 | 0.91149388 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 0.89095033 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87815008 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87438788 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87092084 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85753623 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85127593 |
| 61 | Base excision repair_Homo sapiens_hsa03410 | 0.83142348 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83043423 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82084381 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80842855 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76386946 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72401253 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70267020 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68536032 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64839629 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64623504 |
| 71 | Mismatch repair_Homo sapiens_hsa03430 | 0.64615628 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62804058 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62269757 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62156326 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61367804 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60970728 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60146958 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58434281 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58352515 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56379914 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55868270 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53809025 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51942040 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51830039 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.50700844 |
| 86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48795058 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.48261997 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47773114 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47590569 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47288292 |
| 91 | Homologous recombination_Homo sapiens_hsa03440 | 0.46108407 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46093221 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45544188 |
| 94 | Spliceosome_Homo sapiens_hsa03040 | 0.44750807 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44589397 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44152222 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43797745 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42554415 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40967177 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.40581866 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40253956 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.39240332 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.39018634 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36496195 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35369347 |
| 106 | Ribosome_Homo sapiens_hsa03010 | 0.34844889 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34752438 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34706131 |
| 109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34636169 |
| 110 | Lysine degradation_Homo sapiens_hsa00310 | 0.34562481 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32015270 |
| 112 | Cell cycle_Homo sapiens_hsa04110 | 0.31307327 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31059541 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.30743747 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30407724 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29034965 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28504431 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27540887 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27364411 |
| 120 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26594752 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26372697 |

